{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T13:19:04Z","timestamp":1773494344445,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010822","name":"Science and Technology Bureau of Chengdu","doi-asserted-by":"publisher","award":["2019-YF08-00308-GX"],"award-info":[{"award-number":["2019-YF08-00308-GX"]}],"id":[{"id":"10.13039\/501100010822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.bbrc.2022.12.005","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T13:05:08Z","timestamp":1670245508000},"page":"80-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Biological activity of a new recombinant human coagulation factor VIII and its efficacy in a small animal model"],"prefix":"10.1016","volume":"640","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8500-1907","authenticated-orcid":false,"given":"Junzheng","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaling","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dekuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5631-4266","authenticated-orcid":false,"given":"Hong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2022.12.005_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.blre.2019.03.002","article-title":"Factor VIII: long-established role in haemophilia A and emerging evidence beyond haemostasis","volume":"35","author":"Samuelson Bannow","year":"2019","journal-title":"Blood Rev."},{"key":"10.1016\/j.bbrc.2022.12.005_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41540-021-00202-9","article-title":"Personalized modulation of coagulation factors using a thrombin dynamics model to treat trauma-induced coagulopathy","volume":"7","author":"Ghetmiri","year":"2021","journal-title":"NPJ Syst. Biol. Appl."},{"key":"10.1016\/j.bbrc.2022.12.005_bib3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2001-12-0361","article-title":"Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex","volume":"100","author":"Jenkins","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2022.12.005_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.18388\/abp.2015_1056","article-title":"The factor VIII protein and its function","volume":"63","author":"Mazurkiewicz-Pisarek","year":"2016","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.bbrc.2022.12.005_bib5","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1161\/ATVBAHA.107.155952","article-title":"Intrinsic pathway of coagulation and arterial thrombosis","volume":"27","author":"Gailani","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2022.12.005_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/5584_2016_122","article-title":"Thrombosis and von Willebrand factor","volume":"906","author":"Shahidi","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbrc.2022.12.005_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0268-960X(03)00025-0","article-title":"Activation of factor VIII and mechanisms of cofactor action","volume":"18","author":"Fay","year":"2004","journal-title":"Blood Rev."},{"key":"10.1016\/j.bbrc.2022.12.005_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(15)01123-X","article-title":"The past and future of haemophilia: diagnosis, treatments, and its complications","volume":"388","author":"Peyvandi","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2022.12.005_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-021-00278-x","volume":"7","author":"Berntorp","year":"2021","journal-title":"Haemophilia, Nat. Rev. Dis. Primers"},{"issue":"Suppl 6","key":"10.1016\/j.bbrc.2022.12.005_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the management of hemophilia","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.bbrc.2022.12.005_bib11","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.ymthe.2017.10.009","article-title":"A\u00a0cornucopia of therapies under study for hemophilia","volume":"25","author":"Pierce","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2022.12.005_bib12","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1182\/blood-2016-01-691469","article-title":"Hemophilia A treatment: disruptive technology ahead","volume":"127","author":"Makris","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2022.12.005_bib13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1182\/blood-2013-01-479527","article-title":"Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial","volume":"122","author":"Mannucci","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2022.12.005_bib14","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1182\/blood-2018-01-829523","article-title":"A\u00a0factor VIII-nanobody fusion protein forming an ultrastable complex with VWF: effect on clearance and antibody formation","volume":"132","author":"Muczynski","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2022.12.005_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.32607\/20758251-2013-5-2-19-39","article-title":"Blood clotting factor VIII: from evolution to therapy","volume":"5","author":"Orlova","year":"2013","journal-title":"Acta Naturae"},{"key":"10.1016\/j.bbrc.2022.12.005_bib16","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1182\/blood-2012-10-464164","article-title":"Minimal modification in the factor VIII B-domain sequence ameliorates the murine hemophilia A phenotype","volume":"121","author":"Siner","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2022.12.005_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/ejh.12366","article-title":"Turoctocog alfa (NovoEight\u00ae)--from design to clinical proof of concept","volume":"93","author":"Ezban","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bbrc.2022.12.005_bib18","doi-asserted-by":"crossref","first-page":"10299","DOI":"10.1021\/acs.analchem.5b02078","article-title":"Shear-dependent interactions of von Willebrand factor with factor VIII and protease ADAMTS 13 demonstrated at a single molecule level by atomic force microscopy","volume":"87","author":"Bonazza","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbrc.2022.12.005_bib19","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2016-04-713289","article-title":"Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A","volume":"128","author":"Pipe","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2022.12.005_bib20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/21655979.2017.1279767","article-title":"Production of recombinant coagulation factors: are humans the best host cells?","volume":"8","author":"Swiech","year":"2017","journal-title":"Bioengineered"},{"key":"10.1016\/j.bbrc.2022.12.005_bib21","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/ijlh.12424","article-title":"Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients?","volume":"37","author":"Martinuzzo","year":"2015","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.bbrc.2022.12.005_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/ijlh.12499","article-title":"In\u00a0vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficiencies","volume":"38","author":"Toulon","year":"2016","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.bbrc.2022.12.005_bib23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.moh.0000130308.37353.d4","article-title":"The blood coagulation cascade","volume":"11","author":"Schenone","year":"2004","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bbrc.2022.12.005_bib24","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3390\/biology10080704","article-title":"Novel severe hemophilia A mouse model with factor VIII intron 22 inversion","volume":"10","author":"Han","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.bbrc.2022.12.005_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/13543784.2020.1722999","article-title":"Investigational drugs to treat hemophilia","volume":"29","author":"Franchini","year":"2020","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.bbrc.2022.12.005_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100849","article-title":"Perspective - the case for zero bleeds and drug bioequivalence in the treatment of congenital hemophilia A in 2021","volume":"50","author":"Di Minno","year":"2021","journal-title":"Blood Rev."},{"key":"10.1016\/j.bbrc.2022.12.005_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/cts.12544","article-title":"Assessment of relative bioavailability of moroctocog alfa and moroctocog alfa (AF-CC) in subjects with severe hemophilia A","volume":"11","author":"Korth-Bradley","year":"2018","journal-title":"Clin. Transl. Sci."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22016709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22016709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:44:04Z","timestamp":1762094644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X22016709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":27,"alternative-id":["S0006291X22016709"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.12.005","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological activity of a new recombinant human coagulation factor VIII and its efficacy in a small animal model","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}